Li JX, Hou LH, Gou JB, Yin ZD, et al. Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial. Lancet Infect Dis 2023 Jun 20:S1473-3099(23)00350.
PMID: 37352880